Rizzo Laboratory

Alumni

Graduates

	Plamen P. Christov – Ph.D., 2007 Thesis: “Synthesis and In Vitro Replication of N5-alkylated Formamidopyrimidine (FAPy-dGuo) Adducts.” Post-Doctoral Research Associate at Vanderbilt University, Department of Chemistry. Currently a Drug Discovery Scientist I with the Vanderbilt Institute of Chemical Biology, Chemical Synthesis Core, Vanderbilt University School of Medicine, Nashville, TN
	Jimmy Stover – Ph.D., 2006 Thesis: “Synthetic, Replicative, and Oxidative Studies of C8- and N2-Deoxyguanosine Adducts of the Dietary Mutagen 2-Amino-3-methylimidazo[4,5-f]quinoline.” Post-Doctoral Research Associate at The Scripps Research Institute with Dale Boger. President and Co-Founder of Diagnovus, Nashville, TN. Currently Vice President, Life Sciences at Aegis Sciences Corporation
	Angela K. Goodenough (Brock) – Ph.D., 2005 Thesis: “DNA Adducts of Bis-Electrophiles“ Post-doctoral Research Associate at the Wadsworth Center, New York State Dept. of Health with Robert Turesky. Senior Research Investigator at Bristol-Myers Squibb Pharmaceuticals, Princeton, NJ. Currently a Senior Research Investigator II at Amicus Therapeutics, Cranbury, NJ
	Eric Elmquist – Ph.D., 2005 Thesis: “Site-Specific Synthesis and Analysis of Oligonucleotides Containing the C8-Deoxyguanosine Adducts of the Dietary Mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ).” Post-Doctoral Research Associate with Peter C. Dedon, Division of Biological Engineering, MIT. Development Director with Compliant Therapeutics, Cool Springs Life Science Center, Cool Springs, TN
	Hao Wang – Ph.D., 2003 Thesis: “DNA Adducts Derived from Lipid Peroxidation. Site-Specific Synthesis and Reactivity of Oligonucleotides Containing Stereochemically Defined Trans-4-Hydroxynonenal and Malondialdehyde Adducts.” Post-Doctoral Research Associate at Vanderbilt University. Currently a Research Scientist at Idera Pharmaceuticals, Cambridge, MA.
	Jason Buck – Ph.D., 2002 Thesis: “Stereocontrolled de Novo Synthesis of 2′,3′-Dideoxynucleosides via Photoinduced Electron-Transfer Deoxygenation.” Currently a Research Scientist in the Vanderbilt Institute of Imaging Science, Vanderbilt University School of Medicine, Nashville, TN.
	Dan Prudhomme – Ph.D., 2002 Thesis: “An Improved de Novo Synthesis of 2′-Deoxynucleosides via Photochemical Deoxygenation of Ribonucleosides.” Post-Doctoral Research Associate with Professor Lawrence J. Marnett, Department of Biochemistry, Vanderbilt University School of Medicine (2002-2004). Currently a Research Scientist at Gilead Sciences, Forest City, CA.
	Sharon Parker – Ph.D., 1999 Thesis: “Synthetic Approaches to Designed Enediynes for Use in Cancer Chemotherapy” Post-Doctoral Research Associate with Professor Ned A. Porter, Department of Chemistry, Vanderbilt University (2000-2001) and Proctor & Gamble, Cincinnati, OH (2001-2002). Currently a stay-at-home mother of three.

	Craig Garmendia – M.S., 2008 Thesis: “In Vitro Replication Studies of Oligonucleotides Containing Site-Specific DNA Adducts in Frameshift-Prone Sequences.” Currently a Consumer Safety Officer of the U.S. Food and Drug Adminstration, Miami Branch Office.
	Kris H. Franklin – M.S., 2004 Thesis: “Amino Acid and Peptide Promoted Catalysis of 1,N2-Hydroxypropano Adducts of Deoxyguanosine: A Biomimetic Model for the Interaction of α,β-Unsaturated Aldehydes With DNA. Currently the Chief Scientific Officer at Trinity Medical Services, LLC, Mandeville, LA.
	David A. Jones – M.S., 2003 Thesis: “The Effects of an N1-Hydrogen Bond on the Redox Properties of Flavoenzyme Catalysis.“
	Samuel A. Brown – M.A., 1999; J. D., 2010, Kent School of Law. Currently an attorney at Synthesis Intellectual Property, LLC, Evanston, IL
	John S. Siler – M.S., 1995 Thesis: “2,2’-Functionalization of 1,1’-Binapthyl-2,2’-bis-triflate”Currently and Environmental Scientist at EnSafe, Nashville, TN
	Jacqueline D. Brisbane – M.S., 1995 Thesis: “Regioselective Synthesis and Deoxygenation of Thionobenzoates”
	Kathy L. Wheeler – M.A. 1995

	Brett J. Doliner – B.S., 2015;
	Kyu Jun Son – B.A., 2011; Currently a fourth year medical student at Tufts University School of Medicine
	Nadia Ansari – B.A., 2010; Currently a Forensic Toxicologist Lab Tech at Travis County Medical Examiner’s Office, Austin, TX
	Guillermo R. Alas – B.A., 2008: currently a graduate student in the Department of Chemistry, Georgia Institute of Technology.
	Andrew T. Voglewede – B.S., 2005, M. D., 2009, University of Virginia, School of Medicine.
	Julia A. Jacobs – B. A., 2005; M.D., 2009, University of Louisville, School of Medicine.
	Stephen T. Duncan – B. A., 2003; M.D., 2007, Vanderbilt University School of Medicine
	Bryan H. Chang – B.A., 2000; Scientist, Chiron, Inc. (2000-2003); Ph.D, 2009, Department of Chemistry & Chemical Biology, Harvard University with Gavin MacBeath. M.D., 2014, Emory University School of Medicine
	Justin J. Hasford – B.S. (High Honors), 1998. Honors Thesis: Conformational and Electronic Control of Flavin Redox Chemistry.; J. D., 2003, University of Virginia, School of Law; Currently a Partner at Finnegan, Henderson, Farabow, Garrrett and Dunner (Washington, DC).
	Rongson Pongdee – B.A., 1997; Ph. D., 2003 from Texas A&M University with Gary Sulikowski; Post-Doctoral Research Associate at the University of Texas with Ben Lui; Currently an Associate Professor of Chemistry at the University of the South (Sewanee, TN).
	Kathryn E. Garretson – B.A. 1996; M.P.H., 1997, University of Alabama, Birmingham
	William Kemnitzer – B.A.1993, Ph. D., 1998 from University of South Carolina with Tom Bryson; Post-Doctoral Research Associate at the University of California, Irvine with James Nowick; Currently a research scientist at Maxim Pharmaceutical (San Diego, CA).

Former Post-doctoral Associates

	Katya V. Petrova – 2004-2011 Ph.D., Sofia University, Sofia, Bulgaria. Currently a Commissioner’s Fellow, U.S. Food and Drug Administration, National Center for Toxicological Research, Jefferson, AR
	Zhiwei Wang – 1996-2001 Ph. D ., 1996, Lanzhou University, Lanzhou, PRC with Yulin Li. Research Scientist at the Genomics Institute of the Novartis Research Foundation, San Diego, CA (2001-2009). Associate Director of Medicinal Chemistry at BioDuro, Beijing, China. Currently Senior Vice-president of Chemistry at BeiGene, Beijing, China.
	Jeong-Aei Park – 1995-1999 Ph.D., 1995, Mississippi State University with Keith Mead. Research Fellow at the Fredrick Cancer Research and Development Center with Christopher J. Michejda (1999-2003). Currently a Research Scientist at Purdue Pharma, Cranbury, NJ.
	Fengli Guo – 1998-2001 Ph.D., 1996, Lanzhou University, Lanzhou, PRC with Zhongli Liu. Senior Associate Scientist at Pfizer, Inc., San Diego, CA (2001-2009). Currently self-employed.
	Ravi Kumar Jalluri – 2002-2005 Ph. D., Osmania University, Hyderabad, India with Apurba Datta. Currently a Principal Scientist at Neuland Laboratories Ltd., Hyderabad, India